Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers

Preeti Putcha; Jiyang Yu; Ruth Rodriguez-Barrueco; Laura Saucedo-Cuevas; Patricia Villagrasa; Eva Murga-Penas; Steven N. Quayle; Min Yang; Veronica Castro; David Llobet-Navas; Daniel Birnbaum; Pascal Finetti; Wendy A. Woodward; Fran?ois Bertucci; Mary L. Alpaugh; Andrea Califano; Jose Silva

首页> 外文期刊>Breast Cancer Research >Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers

【24h】

Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers

机译：勘误至：HDAC6活性是炎性乳腺癌的非致癌基因上枢

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Breast Cancer Research》 |2017年第1期|共1页
作者
Preeti Putcha; Jiyang Yu; Ruth Rodriguez-Barrueco; Laura Saucedo-Cuevas; Patricia Villagrasa; Eva Murga-Penas; Steven N. Quayle; Min Yang; Veronica Castro; David Llobet-Navas; Daniel Birnbaum; Pascal Finetti; Wendy A. Woodward; Fran?ois Bertucci; Mary L. Alpaugh; Andrea Califano; Jose Silva;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类泌尿生殖器肿瘤;
关键词

相似文献

外文文献
中文文献
专利

1. HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers [J] . Preeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, Breast Cancer Research . 2015,第1期

机译：HDAC6活性是炎性乳腺癌的非癌基因成瘾中心
2. Erratum to Design, Synthesis and Biological Evaluation of a Phenyl Butyric Acid Derivative, N-(4-chlorophenyl)-4- phenylbutanamide: A HDAC6 Inhibitor with Anti-proliferative Activity on Cervix Cancer and Leukemia Cells [J] . Anti-cancer agents in medicinal chemistry . 2018,第8期

机译：错误以设计，合成和生物学评价苯基丁酸衍生物，N-（4-氯苯基）-4-苯基丁酰胺：HDAC6抑制剂对子宫颈癌和白血病细胞的抗增殖活性
3. Anti-metastatic activity of MPTOG211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo [J] . Hsieh Yi-Ling, Tu Huang-Ju, Pan Shiow-Lin, Biochimica et biophysica acta. Molecular cell research . 2019,第6期

机译：MPTOG211，一种新型HDAC6抑制剂，在体外和体内的人乳腺癌细胞中的抗转移活性
4. Stilbene analogues as inhibitors of breast cancer Stem cells through P-glycoprotein efflux; A 3D quantitative structure-activity relationship study (Inhibitory activity of stilbenes analogues on breast cancer stem cells) [C] . Anushree Tripathi, Krishna Misra 2016 International Conference on Bioinformatics and Systems Biology . 2016

机译：Stilbene类似物通过P-糖蛋白外排作为乳腺癌干细胞的抑制剂； 3D定量结构-活性关系研究（Stilbenes类似物对乳腺癌干细胞的抑制活性）
5. HDAC6 as a Therapeutic Candidate in the Treatment of Inflammatory Breast Cancers. [D] . Putcha, Preeti. 2015

机译：HDAC6作为炎性乳腺癌的治疗候选药物。
6. Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers [O] . Preeti Putcha, Jiyang Yu, Ruth Rodriguez-Barrueco, 2017

机译：勘误至：HDAC6活性是炎性乳腺癌的非致癌基因上枢
7. HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers [O] . 2015

机译：HDAC6活性是炎症性乳腺癌的非癌基因成瘾中心

Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers

著录项

相似文献

相关主题

期刊订阅